Companies

Regeneron Pharmaceuticals

Regeneron combines proprietary antibody and genetics platforms to discover medicines in immunology, oncology, and ophthalmology. Its Regeneron Genetics Center has sequenced millions of exomes, fueling target discovery across its pipeline.

Details

Industry

Biopharma

R&D Spend

$4.4B